Foxconn Confirms Death in China

Related Link: 

Contract manufacturer Foxconn said an employee died in Shenzhen, China, reigniting concerns about the Apple Inc. supplier's labor practices.

China Puts Microsoft Under Microscope

Related Link: 

Chinese officials said they are investigating whether Microsoft violated Chinese antimonopoly laws, citing compatibility issues with the tech firm's Windows and Office software.

French Mall Owner to Buy Dutch Rival

Related Link: 

French real-estate company Klepierre, which owns shopping malls across Europe, is to buy Dutch rival Corio for $9.68 billion in a deal that will create an industry leader.

Hyundai Heavy Posts Record Loss

Related Link: 

South Korea's Hyundai Heavy Industries posted its worst quarterly loss ever, hurt by a stronger local currency and discounts it has offered since last year to prop up sales amid a slowdown in the global shipbuilding industry.

BP Warns on Russia Sanctions

Related Link: 

BP reported a rise in second-quarter profit, boosted by its investment in Russian energy group Rosneft, but warned that further economic sanctions on Russia could adversely impact its business.

'Ramadan Rush' Gives U.K. Retail a Lift

Related Link: 

High-end stores in London have long sold gifts to well-heeled Muslim tourists for the holy month of Ramadan, but more middle-market outlets are beginning to feel the effect as well.

Honda Net Profit Grows 20%

Related Link: 

Honda Motor Co. says its earnings rose 20% in the latest quarter, when it benefited from growth in global auto sales, but was held back by delayed model introductions.

Orange Helped by Cost Cuts

Related Link: 

France's Orange said cost savings continued to help offset declining revenue in some of its biggest markets in the first half.

Renault Profit Surges on Cost-Cutting

Related Link: 

Renault reported a steep rise in first-half profit, as the French car maker benefited from a cost cutting drive and the absence of provisions that hurt its performance in the same period last year.

Roche Leukemia Treatment Approved

Related Link: 

Roche said that the European Commission has approved its Gazyvaro treatment for chronic lymphocytic leukemia, the most common form of the disease.

Syndicate content